Before dealing with the individual names in this post, I just want to repeat my concerns about the mania that seems to be gripping a class of retail investors to find short squeeze targets. As I mentioned to many subscribers, my background is analytical and it is basically analysis that I try to provide to…
As subscribers are aware, it is my practice to review the earnings for most of our portfolio companies-and a few other companies that are likely to be of interest to many subscribers. I will comment briefly on the quarter that Microsoft reported. In fact, it was fantastic. Just about every business metric that most investors…
We are selling 400 shares of FSLY in our portfolio at an early morning price of $103.89. This was a trade limit we set pre-market and as such it may be different than the price of the shares at the time readers receive this post. The net value of the sale was $41,540 and the…
As noted in our portfolio commentary, we purchased a position in the shares of Citrix (CTXS) in our Income/stability portfolio at Monday’s opening price of $131.49. This transaction used up the prior cash balance; our purchase cost $17,760. In our portfolio commentary, we mistakenly reported that we had purchased 225 shares-my bad. We make an…
Summary Several months ago, New Relic introduced its second iteration of New Relic 1. The offering is designed to compete more effectively with Datadog. In some ways, it is a case of imitation being the sincerest form of flattery. The quarterly results reported by NR in the first quarter of general availability of the new…
Alteryx: Yesterday, AYX and Snowflake announced a partnership that enhances the integration between the Snowflake platform and what Alteryx now calls its analytic process automation solution set. Alteryx shares were up 7%+ on the basis of the announcement. Alteryx is a 7%+ weighting in our high-growth portfolio. Snowflake is perhaps the leading platform these days…
Summary Enterprise software turned in a spectacular performance in 2020. My tea leaves suggest that the space will continue to outperform broad indices in 2021. I think a reasonable portfolio should focus on those companies who experienced demand headwinds in all or part of last year. I have taken a portfolio approach to making recommendations.…
We are enlarging our AYX position from about 5% to 7.5%; we have bought 150 shares at a price of $111.49. I get questions sometimes about the price we buy and sell in the model portfolio. We actually have a model portfolio that we manage on behalf of a specific (unidentified) client. Very often we…
As mentioned earlier this week, we wanted to finish selling the RPD position. Today the shares advanced a bit and we finished disposing of the position. We are trying to direct some of the investments in the portfolio into names that we believe will reap outsize benefits from the end of the pandemic. Shift4 has…
We made 2 portfolio changes this afternoon. We sold 50% of our position in Rapid 7. The sale does not reflect any foreshadowing of deteriorating growth. We think the space is strong and that Rapid 7 is gaining share in the SIEM market with competitive wins against Splunk. But the shares have about doubled in…